Abstract
The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.
| Original language | English |
|---|---|
| Pages (from-to) | 294-297 |
| Number of pages | 4 |
| Journal | Current Hypertension Reports |
| Volume | 7 |
| Issue number | 4 |
| Publication status | Published - Aug 2005 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'Intermediate versus hard end points in clinical trials on hypertension'. Together they form a unique fingerprint.
Cite this
Grassi, G. (2005). Intermediate versus hard end points in clinical trials on hypertension. Current Hypertension Reports, 7(4), 294-297.